Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

American Conference Institute (ACI)'s Novel Therapeutic Modalities

Loeb & Loeb LLP is proud to sponsor the American Conference Institute’s (ACI) 2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities taking place from March 20-21, 2024 where partner, Ryan Hagglund will be speaking on the panel "Collaborate to Innovate: Ownership and IP Challenges in Different Categories of Partnerships and Collaborations" and associate, Dan Liu will be speaking on the panel "Navigating the Next Frontier of Patent Disputes and Licensing Opportunities in Novel Therapeutics."

From the event website:
American Conference Institute is pleased to present the 2nd Annual Forum on IP, Funding, and Tech Strategies for Novel Therapeutic Modalities, where the brightest minds in RNA, gene editing, and regenerative medicine converge to shape the future of this rapidly evolving field. Positioned at the critical juncture of innovation and commercialization, this premier event is dedicated to unraveling the complex interplay of evolving market trends, dynamic regulatory frameworks, and critical intellectual property strategies.

For more information, including how to register, please visit the event website.